Full text

 

10.1186/s40409-018-0156-9
 

Research article - Vol. 24, 2018

 

Effect of phospholipase A2 inhibitors during infection caused by Leishmania (Leishmania) amazonensis

 

Maria L. A. C. Bordon1 3, Márcia D. Laurenti1, Susan Pereira Ribeiro2, Marcos H. Toyama3, Daniela de O. Toyama4, Luiz Felipe D. Passero3

 

1 Laboratory of Pathology of Infectious Diseases (LIM-50), Medical School, University of São Paulo (USP), Av. Dr. Arnaldo, 455, São Paulo, SP CEP 01246903, Brazil

2 Pathology Department, Case Western Reserve University, 2103 Cornell Rd, room 5503, Cleveland, OH 44106, USA

3 São Paulo State University (UNESP), Institute of Biosciences, São Vicente, Praça Infante Dom Henrique, s/n, 11330-900 São Vicente, SP, Brazil

4 School of Dentistry, Camilo Castelo Branco University (Unicastelo), Rua Carolina Fonseca, 584, São Paulo, SP CEP 08230-030, Brazil

 

ABSTRACT

Background:

Lipid metabolites play an important role in parasite differentiation and virulence. Studies have revealed that Leishmania sp. uses prostaglandins to evade innate barriers, thus enabling the parasites to survive inside immune cells. Despite the role of the enzyme Phospholipase A2 (PLA2) in prostaglandins production, few studies have investigated the role of parasite PLA2 during the interaction between L. (L.) amazonensis and the host (in vitro and in vivo) immune cells.

 

Methods:

In the present work, the leishmanicidal effect of PLA2 inhibitors, methyl arachidonyl fluorophosphonate (MAFP), bromoenol lactone (BEL) and aristolochic acid (AA) were investigated in vitro (promastigote and intracellular amastigote forms of L. (L.) amazonensis) and during in vivo infection using BALB/c mice.

 

Results:

The aforementioned inhibitors were deleterious to promastigote and amastigote forms of the L. (L.) amazonensis and were non-toxic to peritoneal macrophages from BALB/c mice. L. (L.) amazonensis-infected BALB/c mice treated with the inhibitor BEL presented decreased lesion size and skin parasitism; however, BEL treatment induced hepatotoxicity in BALB/c mice.

 

Conclusions:

Results presented herein suggested that PLA2 inhibitors altered L. (L.) amazonensis viability. In spite of liver toxicity, treatment with BEL was the most selective compound in vitro, as well in vivo, resulting in lower skin parasitism in the infected mice. These findings corroborate the role of PLA2 in parasite virulence and maintenance in vertebrate hosts, and suggest that molecules structurally related to BEL should be considered when planning compounds against Leishmania sp.

 

Keywords: Leishmania (Leishmania) amazonensis; Macrophages; BALB/c mice; Phospholipase A2; Phospholipase A2 inhibitors

 

Received: March 02, 2018.

Accepted: August 01, 2018.

Published: August 27, 2018.

 

Correspondence: felipepassero@yahoo.com.br ; felipepassero@clp.unesp.br

 

Authors’ contributions

Formal analysis: MLACB, LFDP. Investigation: MLACB, LFDP. Methodology: MLACB, LFDP. MDL, MHT, DOT, SPR, LFDP. Writing: LFDP, MDL, MHT, DOT, SPR, LFDP Funding acquisition: LFD, MDL, MHT. All authors read and approved the final manuscript.

 

Competing interests

The authors declare that they have no competing interests.